More Business Wire
View Older Stories View Newer Stories-
Fastly to Announce Third Quarter 2024 Financial Results
-
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
-
UserTesting Achieves AWS ISV Accelerate Status, Increasing the Accessibility of its Human Insight Platform and Accelerating Innovation
-
LevelBlue Report Reveals Financial Services Leaders Weigh Trade-Offs Between Innovation and Security
-
Nimbus Therapeutics to Present First Preclinical Data from Werner Syndrome Helicase Program at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
-
Longhorn Vaccines and Diagnostics to Present Data on Universal Influenza Vaccine LHNVD-110 and Antimicrobial Resistant Sepsis Vaccine LHNVD-303 at IDWeek 2024
-
Avanci announces 5G Vehicle license agreement with Toyota
-
MagBio Launches Short Fragment Depletor - 10 High Throughput Kit (SFD-10HT); Bead-based Reagent That Progressively Depletes DNA Fragments <10 kb
-
JPMorgan Chase Commercial Banking and Syracuse University’s D’Aniello IVMF Announce New Cohort of Veteran and Military-Spouse Led Startups for CEOcircle Program
-
New Data Privacy Trends Help Drive Growth in Frequency and Severity of Large Cyber Claims: Allianz
-
Ambulnz by DocGo and Bayhealth Renew Partnership in Delaware, Extending Contract for Three Years
-
GeoPark Announces Third Quarter 2024 Operational Update
-
Ohmium Partners with Lewis County Transit to Launch Washington State's First Zero Emission Transportation Network
-
Bowman Contracted to Provide Support Services for Virginia Department of Transportation Design-Build Projects
-
Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
-
Owens Corning to Announce Third-Quarter Financial Results on November 6
-
CIOs Sound Alarm on Network Security as a Top Priority as AI Fuels New Risks and Challenges
-
Metals Acquisition Limited Raises ~A$150 Million (~US$103 Million) Through Successful Placement
-
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
-
CareDx Appoints Jing Huang Chief Data and AI Officer
-
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Meet Primary Endpoint in Psoriasis Patients
-
Ferraro Foods Acquires Botticelli Food Service, Expanding Reach and Strengthening Market Position in the Tri-State Region and Beyond
-
DRIVE Roadside Revolutionizes Roadside Assistance with Free On-Demand Towing App – Available Now!
-
Alnylam Submits Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for Vutrisiran for the Treatment of Transthyretin Amyloidosis with Cardiomyopathy
-
Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting
-
Audax Private Debt Hires John Wierzba to Lead Wealth Effort
-
Veritone Expands iDEMS Data Integrations to Enhance Public Safety and Law Enforcement Efficiency
-
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
-
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-Omics
-
Sonendo Executes Asset Purchase Agreement to Acquire Biolase Assets
-
MyGuava Partners with QPR to Unveil Exclusive Fan Payment Cards and Exciting Rewards
-
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
-
Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
-
D-Wave Brings Quantum Optimization to 2024 INFORMS Annual Meeting
-
QuidelOrtho Announces New R&D Executive Leader
-
New Prospective, Multicenter Study Presented at SMR Demonstrates Castle Biosciences’ DecisionDx®-Melanoma Test Provides Significant Risk Prediction for Patients with Cutaneous Melanoma, Adding Valu
-
InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges
-
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
-
clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors
-
Kinterra Capital Affiliate Completes Acquisition of Nevada Copper’s Open Pit and Underground Copper Projects
-
Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024
-
AECOM selected as designers to support major capital project delivery for Southern Water
-
Trinity Industries, Inc. Announces Date for Earnings Release
-
VF Corporation to Host Investor Day on October 30, 2024
-
Wallbox Announces Timing of its Third Quarter 2024 Financial Results
-
Ewoyaa Lithium Project Receives Mine Operating Permit
-
Helen of Troy Limited Reports Second Quarter Fiscal 2025 Results
-
New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio
-
Options Announces Landmark Global Expansion with Strategic Launch of New Office in Sydney, Australia
-
Trane Technologies Schedules Third Quarter 2024 Earnings Conference Call
